- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 253/08 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 253/08
Total number of patents in this class: 84
10-year publication summary
9
|
9
|
7
|
2
|
5
|
7
|
2
|
3
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2945 |
10 |
Merck Patent GmbH | 5849 |
9 |
Theravance Biopharma R&D IP, LLC | 517 |
8 |
Bristol-myers Squibb Company | 4886 |
5 |
Bayer Pharma AG | 1085 |
5 |
Gilead Sciences, Inc. | 1949 |
4 |
Glaxosmithkline Intellectual Property Development Limited | 737 |
2 |
Dana-Farber Cancer Institute, Inc. | 2531 |
2 |
Ranbaxy Laboratories Limited | 364 |
2 |
University of Greenwich | 73 |
2 |
Corteva Agriscience LLC | 2677 |
2 |
Merck Sharp & Dohme LLC | 3742 |
2 |
LG Display Co., Ltd. | 12870 |
1 |
Janssen Pharmaceutica N.V. | 3625 |
1 |
Pfizer Inc. | 3373 |
1 |
Bayer Schering Pharma AG | 431 |
1 |
OSRAM GmbH | 2414 |
1 |
Purdue Research Foundation | 3472 |
1 |
CHDI Foundation, Inc. | 108 |
1 |
Cytovia, Inc. | 13 |
1 |
Other owners | 23 |